FXM Research, Corp.

Miami, Florida 33175

0 studies enrolling now · 16 studies all time

What they study most

Acne Vulgaris, Actinic Keratoses, Atopic Dermatitis Eczema, Onychomycosis, Psoriasis, Rosacea, Tinea Pedis

Studies at this site

• A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis — Completed
• Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea — Completed
• Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis — Completed
• Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis — Completed
• A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris — Completed
• Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis — Completed
• Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris — Completed
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• BE Study of Naftifine HCL — Completed
• A Study of DER 45-EV Gel to Treat Rosacea — Completed
• A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris — Completed
• The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed
• A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris — Completed
• A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea — Completed
• A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris — Completed